HomeAPLS • NASDAQ
add
Apellis Pharmaceuticals Inc
Nakaraang pagsara
$17.89
Sakop ng araw
$17.57 - $17.92
Sakop ng taon
$16.10 - $30.48
Market cap
2.28B USD
Average na Volume
2.11M
P/E ratio
100.35
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 199.91M | -5.94% |
Gastos sa pagpapatakbo | 147.10M | 21.09% |
Net na kita | -58.95M | -62.16% |
Net profit margin | -29.49 | -72.36% |
Kita sa bawat share | -0.47 | -62.07% |
EBITDA | -50.82M | -97.59% |
Aktuwal na % ng binabayarang buwis | -0.53% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 467.79M | 12.41% |
Kabuuang asset | 1.08B | 21.49% |
Kabuuang sagutin | 705.11M | 7.40% |
Kabuuang equity | 370.15M | — |
Natitirang share | 127.83M | — |
Presyo para makapag-book | 6.13 | — |
Return on assets | -11.98% | — |
Return on capital | -14.86% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -58.95M | -62.16% |
Cash mula sa mga operasyon | -14.18M | -173.22% |
Cash mula sa pag-invest | -108.00K | -440.00% |
Cash mula sa financing | 1.26M | 131.48% |
Net change in cash | -12.84M | -189.33% |
Malayang cash flow | -9.31M | -116.79% |
Tungkol
Itinatag
2009
Headquarters
Website
Mga Empleyado
736
